NCT00647842View on ClinicalTrials.gov

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Healthy
Interventions
DRUG

Fentanyl Transdermal System 25 mcg/h + Bioclusive Overlay

single application

DRUG

Fentanyl Transdermal System 25 mcg/h

single application

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00647842 - Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System | Biotech Hunter | Biotech Hunter